Your browser doesn't support javascript.
loading
Systematic Functional Characterization of Candidate Causal Genes for Type 2 Diabetes Risk Variants.
Thomsen, Soren K; Ceroni, Alessandro; van de Bunt, Martijn; Burrows, Carla; Barrett, Amy; Scharfmann, Raphael; Ebner, Daniel; McCarthy, Mark I; Gloyn, Anna L.
Afiliação
  • Thomsen SK; Oxford Centre for Diabetes, Endocrinology & Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, U.K.
  • Ceroni A; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, U.K.
  • van de Bunt M; Oxford Centre for Diabetes, Endocrinology & Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, U.K.
  • Burrows C; Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, U.K.
  • Barrett A; Oxford Centre for Diabetes, Endocrinology & Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, U.K.
  • Scharfmann R; Oxford Centre for Diabetes, Endocrinology & Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, U.K.
  • Ebner D; INSERM U1016, Institut Cochin, Université Paris Descartes, Paris, France.
  • McCarthy MI; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, U.K.
  • Gloyn AL; Oxford Centre for Diabetes, Endocrinology & Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, U.K.
Diabetes ; 65(12): 3805-3811, 2016 Dec.
Article em En | MEDLINE | ID: mdl-27554474
ABSTRACT
Most genetic association signals for type 2 diabetes risk are located in noncoding regions of the genome, hindering translation into molecular mechanisms. Physiological studies have shown a majority of disease-associated variants to exert their effects through pancreatic islet dysfunction. Systematically characterizing the role of regional transcripts in ß-cell function could identify the underlying disease-causing genes, but large-scale studies in human cellular models have previously been impractical. We developed a robust and scalable strategy based on arrayed gene silencing in the human ß-cell line EndoC-ßH1. In a screen of 300 positional candidates selected from 75 type 2 diabetes regions, each gene was assayed for effects on multiple disease-relevant phenotypes, including insulin secretion and cellular proliferation. We identified a total of 45 genes involved in ß-cell function, pointing to possible causal mechanisms at 37 disease-associated loci. The results showed a strong enrichment for genes implicated in monogenic diabetes. Selected effects were validated in a follow-up study, including several genes (ARL15, ZMIZ1, and THADA) with previously unknown or poorly described roles in ß-cell biology. We have demonstrated the feasibility of systematic functional screening in a human ß-cell model and successfully prioritized plausible disease-causing genes at more than half of the regions investigated.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Células Secretoras de Insulina Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Células Secretoras de Insulina Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article